SCHEMBL8262196

SCHEMBL8262196

Cc1cc(CC(=O)NS(=O)(=O)c2ccc(Sc3ccccn3)s2)n(-c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 1/20 0.44
NTRK1 P04629 3/20 0.38
ALDH1A1 P00352 5/20 0.36
PTGER3 P43115 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 1/20 0.35
SCN9A Q15858 1/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
TP53 P04637 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPK13 O15264 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809123 0.88 NTRK1 (0.38) NTRK1ALDH1A1ATML3MBTL1HTT
SCHEMBL8262663 0.87 NTRK1 (0.35) NTRK1ALDH1A1ATML3MBTL1HTT
SCHEMBL5808760 0.86 PTGES (0.37) GUSBALDH1A1PTGER3KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL5808028 0.86 NTRK1 (0.35) NTRK1ALDH1A1ATML3MBTL1HTT
SCHEMBL5808980 0.84 LMNA (0.43) NTRK1ALDH1A1ATML3MBTL1HTT
SCHEMBL5804860 0.84 ALDH1A1 (0.42) NTRK1ALDH1A1PTGER3ATML3MBTL1
SCHEMBL5821042 0.84 MAPK13 (0.43) NTRK1ALDH1A1L3MBTL1LMNAMAPK1
SCHEMBL5806376 0.84 NTRK1 (0.37) NTRK1ALDH1A1ATML3MBTL1HTT
SCHEMBL5804805 0.83 MAPT (0.40) NTRK1ALDH1A1L3MBTL1HTTLMNA
SCHEMBL5807701 0.82 MEN1 (0.41) NTRK1ALDH1A1ATML3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006075955-A1 PYRAZOLYL ACYLSULFONAMIDE DERIVATIVES AS ENDOTHELIN CONVERTING ENZYME INHIBITORS AND USEFUL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASTRAZENECA AB (SE) 2006-07-20 WO disclosed